Novavax Plans Site Consolidation; Sees $125m-$127m 3Q Charge

Oct. 22, 2025, 11:13 AM UTC

Novavax executed its planned site consolidation by signing agreements to transfer one U.S.-based facility and sell certain equipment, resulting in $60 million in cash and expected future cost savings of $230 million.

  • Company has moved corporate HQ from 700 Quince Orchard Road to 21 Firstfield Road, Gaithersburg
  • Entered into an assignment of 700 Quince Orchard Road, Gaithersburg, MD facility with AstraZeneca
  • Sees 3Q non-cash charges $125 million - $127 million
  • Assignment of the lease for this facility and sale of certain related assets are both expected to close in January of 2026 and result in $40 million in payments to ...

Learn more about Bloomberg Tax or Log In to keep reading:

See Breaking News in Context

From research to software to news, find what you need to stay ahead.

Already a subscriber?

Log in to keep reading or access research tools and resources.